Literature DB >> 33585287

The Threshold Effect: Lipopolysaccharide-Induced Inflammatory Responses in Primary Macrophages Are Differentially Regulated in an iRhom2-Dependent Manner.

Joseph Skurski1,2, Garima Dixit1, Carl P Blobel3,4, Priya D Issuree1,2,5, Thorsten Maretzky1,2,5,6.   

Abstract

A well-controlled innate immune response is characterized by a rapid yet self-limiting inflammatory response. Although much is known about the range of inflammatory stimuli capable of triggering an innate immune response, the mechanisms which govern the degree of inflammation induced by inflammatory insults and the mechanisms in place to reset or maintain homeostasis are poorly understood. Tumor necrosis factor (TNF) is a potent early response pro-inflammatory cytokine produced by immune cells following a broad range of insults spanning autoimmunity and metabolic diseases to pathogenic infections. Previous studies have shown that a disintegrin and metalloproteinase (ADAM) 17 controls the release of soluble TNF and epidermal growth factor receptor signaling. Utilizing a genetic model of ADAM17 deficiency through the deletion of its regulator, the inactive rhomboid 2 (iRhom2), we show that loss of ADAM17 activity in innate immune cells leads to decreased expression of various cytokines in response to low levels of pathogen-associated molecular pattern (PAMP) stimulation but not at high-dose stimulation. In addition, TNF receptor (TNFR) 1/2-deficient bone marrow-derived macrophages yielded significantly reduced TNF expression following low levels of PAMP stimulation, suggesting that signaling through the TNFRs in immune cells drives a feed-forward regulatory mechanism wherein low levels of TNF allow sustained enhancement of TNF expression in an iRhom2/ADAM17-dependent manner. Thus, we demonstrate that inflammatory expression of TNF and IL1β is differentially regulated following high or low doses of PAMP stimulation, invoking the activation of a previously unknown regulatory mechanism of inflammation.
Copyright © 2021 Skurski, Dixit, Blobel, Issuree and Maretzky.

Entities:  

Keywords:  ADAM17; LPS; TNF; a disintegrin and metalloproteinase 17; iRhom2; inactive rhomboid 2; lipopolysaccharide; tumor necrosis factor

Mesh:

Substances:

Year:  2021        PMID: 33585287      PMCID: PMC7878383          DOI: 10.3389/fcimb.2020.620392

Source DB:  PubMed          Journal:  Front Cell Infect Microbiol        ISSN: 2235-2988            Impact factor:   5.293


  34 in total

1.  Neutralization of membrane TNF, but not soluble TNF, is crucial for the treatment of experimental colitis.

Authors:  Clémentine Perrier; Gert de Hertogh; Jonathan Cremer; Severine Vermeire; Paul Rutgeerts; Gert Van Assche; David E Szymkowski; Jan L Ceuppens
Journal:  Inflamm Bowel Dis       Date:  2013-02       Impact factor: 5.325

2.  A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells.

Authors:  R A Black; C T Rauch; C J Kozlosky; J J Peschon; J L Slack; M F Wolfson; B J Castner; K L Stocking; P Reddy; S Srinivasan; N Nelson; N Boiani; K A Schooley; M Gerhart; R Davis; J N Fitzner; R S Johnson; R J Paxton; C J March; D P Cerretti
Journal:  Nature       Date:  1997-02-20       Impact factor: 49.962

3.  iRhom2 regulation of TACE controls TNF-mediated protection against Listeria and responses to LPS.

Authors:  David R McIlwain; Philipp A Lang; Thorsten Maretzky; Koichi Hamada; Kazuhito Ohishi; Sathish Kumar Maney; Thorsten Berger; Aditya Murthy; Gordon Duncan; Haifeng C Xu; Karl S Lang; Dieter Häussinger; Andrew Wakeham; Annick Itie-Youten; Rama Khokha; Pamela S Ohashi; Carl P Blobel; Tak W Mak
Journal:  Science       Date:  2012-01-13       Impact factor: 47.728

4.  iRhom2 promotes lupus nephritis through TNF-α and EGFR signaling.

Authors:  Xiaoping Qing; Yurii Chinenov; Patricia Redecha; Michael Madaio; Joris Jth Roelofs; Gregory Farber; Priya D Issuree; Laura Donlin; David R Mcllwain; Tak W Mak; Carl P Blobel; Jane E Salmon
Journal:  J Clin Invest       Date:  2018-03-05       Impact factor: 14.808

5.  Tumor necrosis factor (TNF) receptor type 1 (p55) is a main mediator for TNF-alpha-induced skin inflammation.

Authors:  S Kondo; D N Sauder
Journal:  Eur J Immunol       Date:  1997-07       Impact factor: 5.532

6.  Macrophage-specific metalloelastase (MMP-12) truncates and inactivates ELR+ CXC chemokines and generates CCL2, -7, -8, and -13 antagonists: potential role of the macrophage in terminating polymorphonuclear leukocyte influx.

Authors:  Richard A Dean; Jennifer H Cox; Caroline L Bellac; Alain Doucet; Amanda E Starr; Christopher M Overall
Journal:  Blood       Date:  2008-07-25       Impact factor: 22.113

7.  Pharmacokinetics and pharmacodynamics of DPC 333 ((2R)-2-((3R)-3-amino-3{4-[2-methyl-4-quinolinyl) methoxy] phenyl}-2-oxopyrrolidinyl)-N-hydroxy-4-methylpentanamide)), a potent and selective inhibitor of tumor necrosis factor alpha-converting enzyme in rodents, dogs, chimpanzees, and humans.

Authors:  Mingxin Qian; Stephen A Bai; Bernice Brogdon; Jing-Tao Wu; Rui-Qin Liu; Maryanne B Covington; Kris Vaddi; Robert C Newton; Michael J Fossler; C Edwin Garner; Yuzhong Deng; Thomas Maduskuie; James Trzaskos; James J-W Duan; Carl P Decicco; David D Christ
Journal:  Drug Metab Dispos       Date:  2007-07-26       Impact factor: 3.922

Review 8.  Structure and function: Lipid A modifications in commensals and pathogens.

Authors:  Alex Steimle; Ingo B Autenrieth; Julia-Stefanie Frick
Journal:  Int J Med Microbiol       Date:  2016-03-05       Impact factor: 3.473

Review 9.  Tumour necrosis factor alpha in systemic lupus erythematosus and anti-DNA autoantibody production.

Authors:  R A Mageed; D A Isenberg
Journal:  Lupus       Date:  2002       Impact factor: 2.911

10.  Loss of iRhom2 accelerates fat gain and insulin resistance in diet-induced obesity despite reduced adipose tissue inflammation.

Authors:  Joseph Skurski; Christie M Penniman; Ramasatyaveni Geesala; Garima Dixit; Priyanjali Pulipati; Gourav Bhardwaj; David K Meyerholz; Priya D Issuree; Brian T O'Neill; Thorsten Maretzky
Journal:  Metabolism       Date:  2020-03-02       Impact factor: 8.694

View more
  1 in total

1.  Expression of the Metalloproteinase ADAM8 Is Upregulated in Liver Inflammation Models and Enhances Cytokine Release In Vitro.

Authors:  Tanzeela Awan; Aaron Babendreyer; Justyna Wozniak; Abid Mahmood Alvi; Viktor Sterzer; Lena Cook; Jörg W Bartsch; Christian Liedtke; Daniela Yildiz; Andreas Ludwig
Journal:  Mediators Inflamm       Date:  2021-03-11       Impact factor: 4.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.